Holen Sie sich die Stockscreener-App
46.40
0.74%
0.34
Schlusskurs vom Vortag:
$46.06
Offen:
$46.35
24-Stunden-Volumen:
212.21K
Relative Volume:
0.45
Marktkapitalisierung:
$1.89B
Einnahmen:
$115.18M
Nettoeinkommen (Verlust:
$-36.77M
KGV:
-23.32
EPS:
-1.99
Netto-Cashflow:
$-35.35M
1W Leistung:
+3.55%
1M Leistung:
-7.90%
6M Leistung:
-24.12%
1J Leistung:
+53.95%
1-Tages-Spanne:
$46.11
$47.40
1-Wochen-Bereich:
$44.41
$47.40
52-Wochen-Spanne:
$28.88
$66.54
Rxsight Inc Stock (RXST) Company Profile
Firmenname
Rxsight Inc
Sektor
Branche
Telefon
949-521-7822
Adresse
100 COLUMBIA STREET, ALISO VIEJO
Vergleichen Sie RXST mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RXST
Rxsight Inc
|
46.40 | 1.89B | 115.18M | -36.77M | -35.35M | -1.99 |
|
ABT
Abbott Laboratories
|
118.95 | 208.18B | 41.22B | 5.77B | 6.49B | 2.94 |
|
SYK
Stryker Corp
|
388.14 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
|
BSX
Boston Scientific Corp
|
90.75 | 133.32B | 15.91B | 1.79B | 1.89B | 0.82 |
|
MDT
Medtronic Plc
|
86.27 | 111.27B | 33.00B | 4.29B | 5.50B | 2.71 |
|
EW
Edwards Lifesciences Corp
|
72.07 | 42.66B | 6.60B | 4.16B | 490.10M | 2.34 |
Rxsight Inc Stock (RXST) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-10-29 | Eingeleitet | Jefferies | Buy |
| 2024-08-20 | Bestätigt | Needham | Buy |
| 2024-08-06 | Bestätigt | Needham | Buy |
| 2024-05-07 | Bestätigt | BTIG Research | Buy |
| 2023-12-13 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-12-12 | Eingeleitet | Stifel | Buy |
| 2023-12-04 | Eingeleitet | Morgan Stanley | Overweight |
| 2023-04-13 | Eingeleitet | Oppenheimer | Outperform |
| 2022-12-12 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-08 | Eingeleitet | Needham | Buy |
Alle ansehen
Rxsight Inc Aktie (RXST) Neueste Nachrichten
RxSight (NASDAQ:RXST) Shares Up 1.6%Should You Buy? - MarketBeat
RxSight, Inc. (NASDAQ:RXST) Given Consensus Recommendation of "Buy" by Analysts - MarketBeat
RxSight director Shweta Maniar sells $173,518 in stock By Investing.com - Investing.com Nigeria
RxSight's co-president sells $281,728 in common stock By Investing.com - Investing.com Nigeria
Insider Sell Alert: Shweta Maniar Sells 3,782 Shares of RxSight Inc (RXST) - GuruFocus.com
RxSight, Inc. (NASDAQ:RXST) Q3 2024 Earnings Call Transcript - MSN
Insider Selling: RxSight, Inc. (NASDAQ:RXST) Insider Sells 3,100 Shares of Stock - MarketBeat
RxSight director Shweta Maniar sells $173,518 in stock - Investing.com
RxSight's co-president sells $281,728 in common stock - Investing.com
RxSight (NASDAQ:RXST) Trading Down 0.8%Time to Sell? - MarketBeat
RxSight, Inc. (NASDAQ:RXST) Shares Bought by Algert Global LLC - MarketBeat
RxSight (NASDAQ:RXST) Stock Price Up 1.6%What's Next? - MarketBeat
RxSight (NASDAQ:RXST) Stock Price Up 1.7%Time to Buy? - MarketBeat
Thrivent Financial for Lutherans Acquires Shares of 229,637 RxSight, Inc. (NASDAQ:RXST) - MarketBeat
RxSight (RXST) Upgraded to Buy: Here's What You Should Know - MSN
RxSight (NASDAQ:RXST) Shares Up 1.2%Time to Buy? - MarketBeat
Brown Capital Management LLC Takes Position in RxSight, Inc. (NASDAQ:RXST) - MarketBeat
Victory Capital Management Inc. Raises Position in RxSight, Inc. (NASDAQ:RXST) - MarketBeat
RxSight (NASDAQ:RXST) Stock Price Down 1.7%Time to Sell? - MarketBeat
RxSight, Inc. (NASDAQ:RXST) Position Trimmed by Royce & Associates LP - MarketBeat
RxSight, Inc. (RXST) Reports Break-Even Earnings for Q3 - MSN
Rxsight co-president Ilya Goldshleger sells $363,752 in stock By Investing.com - Investing.com Canada
Rxsight co-president Ilya Goldshleger sells $363,752 in stock - Investing.com
OC500 2024: Ron Kurtz - Orange County Business Journal
GSA Capital Partners LLP Cuts Stock Holdings in RxSight, Inc. (NASDAQ:RXST) - MarketBeat
19,978 Shares in RxSight, Inc. (NASDAQ:RXST) Acquired by Los Angeles Capital Management LLC - MarketBeat
Rxsight's co-president Ilya Goldshleger sells $61,356 in stock By Investing.com - Investing.com Canada
RxSight (NASDAQ:RXST) Trading 3.4% Higher on Insider Buying Activity - MarketBeat
RxSight, Inc. (NASDAQ:RXST) Sees Large Increase in Short Interest - MarketBeat
RA Capital Management, L.P. Expands Stake in RxSight Inc - GuruFocus.com
RxSight Insider Bought Shares Worth $1,014,570, According to a Recent SEC Filing - Marketscreener.com
Rxsight director Corley makes $1.01m stock purchases By Investing.com - Investing.com Canada
Rxsight director Corley makes $1.01m stock purchases - Investing.com India
Where are the Opportunities in (RXST) - Stock Traders Daily
Rxsight's co-president Ilya Goldshleger sells $61,356 in stock - Investing.com
Baillie Gifford & Co. Purchases 60,789 Shares of RxSight, Inc. (NASDAQ:RXST) - MarketBeat
RxSight Inc (RXST) Trading Down 3.15% on Nov 12 - GuruFocus.com
RxSight, Inc. (NASDAQ:RXST) Shares Sold by Lisanti Capital Growth LLC - MarketBeat
RxSight's co-president Ilya Goldshleger sells $170,494 in stock - Investing.com India
RxSight Third Quarter 2024 Earnings: EPS Beats Expectations - Simply Wall St
RxSight, Inc. (NASDAQ:RXST) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock? - Yahoo Finance
RxSight Inc (RXST) Q3 2024 Earnings Call Highlights: Robust Revenue Growth and Strategic Market ... By GuruFocus - Investing.com Canada
RxSight (NASDAQ:RXST) Shares Gap DownHere's What Happened - MarketBeat
RxSight Inc (RXST) Shares Down 12.3% on Nov 8 - GuruFocus.com
RxSight, Inc. Reports Strong Q3 Financial Results - TipRanks
RxSight, Inc. Reports 59 Percent Revenue Growth in Third Quarter on Strength of Light Adjustable Lens Sales - Vision Monday
Rxsight earnings beat by $0.09, revenue topped estimates - Investing.com Canada
RxSight, Inc. (RXST) Tops Q3 EPS by 25c - StreetInsider.com
RxSight, Inc. Reports Third Quarter 2024 Financial Results - The Manila Times
What To Expect From RxSight Inc (RXST) Q3 2024 Earnings - Yahoo Finance
Finanzdaten der Rxsight Inc-Aktie (RXST)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):